{"protocolSection":{"identificationModule":{"nctId":"NCT00639249","orgStudyIdInfo":{"id":"ME1-2"},"secondaryIdInfos":[{"id":"EudraCT number: 2007-004840-60"}],"organization":{"fullName":"M's Science Corporation","class":"INDUSTRY"},"briefTitle":"Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Phase IIa Study of Safety and Motor Function Restoration in Subjects Treated With SA4503 Following Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2009-07","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2008-02"},"primaryCompletionDateStruct":{"date":"2009-06","type":"ACTUAL"},"studyFirstSubmitDate":"2008-03-14","studyFirstSubmitQcDate":"2008-03-14","studyFirstPostDateStruct":{"date":"2008-03-20","type":"ESTIMATED"},"lastUpdateSubmitDate":"2009-07-28","lastUpdatePostDateStruct":{"date":"2009-07-29","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Kazumasa Takao","oldOrganization":"M's Science Corporation"},"leadSponsor":{"name":"M's Science Corporation","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of this study is to evaluate the safety and tolerability of SA4503 in patients recovering from a recent stroke. Secondary, to evaluate the efficacy of SA4503 compared to placebo.","detailedDescription":"Further study details as provided by M's Science Corporation:"},"conditionsModule":{"conditions":["Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":60,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"P","type":"PLACEBO_COMPARATOR","description":"Placebo","interventionNames":["Drug: placebo"]},{"label":"A1","type":"EXPERIMENTAL","description":"SA4503","interventionNames":["Drug: SA4503 Low"]},{"label":"A2","type":"EXPERIMENTAL","description":"SA4503","interventionNames":["Drug: SA4503 High"]}],"interventions":[{"type":"DRUG","name":"placebo","description":"Oral administration","armGroupLabels":["P"]},{"type":"DRUG","name":"SA4503 Low","description":"Oral administration","armGroupLabels":["A1"]},{"type":"DRUG","name":"SA4503 High","description":"Oral administration","armGroupLabels":["A2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Safety and tolerability","timeFrame":"4 weeks"}],"secondaryOutcomes":[{"measure":"NIHSS","timeFrame":"4 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Key Inclusion Criteria:\n\n* Males or females 18 years of age or older\n* Experienced a stroke from 48 to 72 hours before randomization\n* A total score of \\>/=4 on the NIHSS, or \\>/=2 on the upper or lower extremity motor scores of the NIHSS\n* Medically and neurologically stable within 24 hours prior to randomization\n\nKey Exclusion Criteria:\n\n* Patients with transient ischemic attack\n* Patients with stroke in progression\n* Unstable cardiac, hepatic, or renal disease, or other major medical disorder","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Keith W Muir, MD","affiliation":"Southern General Hospital, Glasgow","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Southern General Hospital","city":"Glasgow","country":"United Kingdom","geoPoint":{"lat":55.86515,"lon":-4.25763}}]},"referencesModule":{"references":[{"pmid":"25270629","type":"DERIVED","citation":"Urfer R, Moebius HJ, Skoloudik D, Santamarina E, Sato W, Mita S, Muir KW; Cutamesine Stroke Recovery Study Group. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke. Stroke. 2014 Nov;45(11):3304-10. doi: 10.1161/STROKEAHA.114.005835. Epub 2014 Sep 30."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"C000101789","term":"SA 4503"}],"ancestors":[{"id":"D000018697","term":"Nootropic Agents"}],"browseLeaves":[{"id":"M229042","name":"SA 4503","asFound":"Drug-coated stent","relevance":"HIGH"},{"id":"M20464","name":"Nootropic Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"NootAg","name":"Nootropic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}